Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.517NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.427 (Epsilon)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.427 (Epsilon)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.427 (Epsilon)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.427 (Epsilon)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.429 (Epsilon)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.429 (Epsilon)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.429 (Epsilon)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.429 (Epsilon)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.166ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.166ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.166ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.166NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.4.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.4.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
A.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
A.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.7.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
BF.7.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BF.7.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.99.1 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.99.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.99.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.99.1 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KT.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KT.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KT.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KT.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JC.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JC.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-16984.7China
JC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JC.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.334ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.334ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.334ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.334NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.359ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.359ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.359ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.359NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.302ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.302ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.302ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.302NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.222ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used